JOHN BRABSON





Welcome to John Brabson's homepage.
I am a 2nd-year PhD student at the University of Miami working in the Cimmino Lab.

Contact

John Brabson profile picture

Hi, I'm John.

I am a PhD student in the lab of Luisa Cimmino at the University of Miami studying cancer epigenetics. My research focuses on the role of DNA demethylation by TET enzymes in acute myeloid leukemia, and how modulating oxidized methylcytosines can influcence leukemic progression.

My ongoing projects utilize next-generation sequencing (NGS) technologies to profile the epigenome.

This website is still under development, and will be a place to showcase my data science and bioinformatics portfolio.

Publications Twitter Github
2016 2019 Lab Manager UM - Van Dyken Lab 2022 Lab Manager UM - Cimmino Lab PhD Student UM - Cimmino Lab



Publications

Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
TET2 haploinsufficiency is a driving event in myeloid cancers and is associated with a worse prognosis in patients with acute myeloid leukemia (AML). Enhancing residual TET2 activity using vitamin C increases oxidized 5-methylcytosine (mC) formation and promotes active DNA demethylation via base excision repair (BER), which slows leukemia progression. We utilize genetic and compound library screening approaches to identify rational combination treatment strategies to improve use of vitamin C as an adjuvant therapy for AML. In addition to increasing the efficacy of several US Food and Drug Administration (FDA)-approved drugs, vitamin C treatment with poly-ADP-ribosyl polymerase inhibitors (PARPis) elicits a strong synergistic effect to block AML self-renewal in murine and human AML models. Vitamin-C-mediated TET activation combined with PARPis causes enrichment of chromatin-bound PARP1 at oxidized mCs and γH2AX accumulation during mid-S phase, leading to cell cycle stalling and differentiation. Given that most AML subtypes maintain residual TET2 expression, vitamin C could elicit broad efficacy as a PARPi therapeutic adjuvant.

Epigenetic Regulation of Genomic Stability by Vitamin C
DNA methylation plays an important role in the maintenance of genomic stability. Ten-eleven translocation proteins (TETs) are a family of iron (Fe2+) and α-KG -dependent dioxygenases that regulate DNA methylation levels by oxidizing 5-methylcystosine (5mC) to generate 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). These oxidized methylcytosines promote passive demethylation upon DNA replication, or active DNA demethylation, by triggering base excision repair and replacement of 5fC and 5caC with an unmethylated cytosine. Several studies over the last decade have shown that loss of TET function leads to DNA hypermethylation and increased genomic instability. Vitamin C, a cofactor of TET enzymes, increases 5hmC formation and promotes DNA demethylation, suggesting that this essential vitamin, in addition to its antioxidant properties, can also directly influence genomic stability. This review will highlight the functional role of DNA methylation, TET activity and vitamin C, in the crosstalk between DNA methylation and DNA repair.




Contact

You may view some of my projects on Github. Connect with me on LinkedIn or Twitter. Or, send me an email at john.brabson.phd@gmail.com.

LinkedIn Github Twitter Mail